| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EVA1A | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | KRT8 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | HSPG2 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-08 |
| mRNA | CD151 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | FBXO5 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | KHSRP | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | PHF14 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | RCC2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | ELOVL1 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-08 |
